Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Advenchen Laboratories Nanjing Ltd.

Clinical trials sponsored by Advenchen Laboratories Nanjing Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Healthy volunteers needed to test drug interactions for cancer drug candidate Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

New cancer drug AL58805 enters first human tests

Disease control Recruiting now

This early-stage trial is testing an oral drug called AL58805 in 40 people with advanced solid tumors who have run out of standard treatment options. The main goals are to find a safe dose, identify side effects, and understand how the drug moves through the body. Researchers wil…

Phase 1 • Sponsor: Advenchen Laboratories Nanjing Ltd. • Aim: Disease control

Last updated Jun 26, 2026 17:34 UTC